timolol hemihydrate 5 MG/ML Ophthalmic Solution

What the CMS Formulary Data Shows for timolol hemihydrate 5 MG/ML Ophthalmic Solution

Per the CMS 2026 Part D formulary file, timolol hemihydrate 5 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 2702393, generic name timolol hemihydrate) appears on 66 distinct formulary files spanning 235 Medicare Part D plan offerings - 4.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.3.

Real-world access to timolol hemihydrate 5 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 6,978 Part D beneficiaries filled timolol hemihydrate 5 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $4,906,851 and an average per-beneficiary annual cost of $703.19. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry timolol hemihydrate 5 MG/ML Ophthalmic Solution today.